-
Maternal cardiac function at 19-23 weeks' gestation in the prediction of gestational diabetes mellitus.
Gibbone E, Wright A, Vallenas Campos R, Anzoategui S, Nicolaides KH, Charakida M.
Ultrasound Obstet Gynecol 2021;58:77-82. pdf -
Paired maternal and fetal cardiac functional measurements in women with gestational diabetes mellitus at 35-36 weeks' gestation.
Aguilera J, Semmler J, Coronel C, Georgiopoulos G, Simpson J, Nicolaides KH, Charakida M.
Am J Obstet Gynecol 2020;223:574.e1-574.e15. pdf -
Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study.
Ling HZ, Jara PG, Bisquera A, Poon LC, Nicolaides KH, Kametas NA.
BJOG 2020;127:1018-1025. pdf -
Maternal cardiac function in gestational diabetes mellitus at 35-36 weeks' gestation and 6 months postpartum.
Aguilera J, Sanchez Sierra A, Abdel Azim S, Georgiopoulos G, Nicolaides KH, Charakida M.
Ultrasound Obstet Gynecol 2020;56:247-254. pdf -
Maternal cardiac function at 19-23 weeks' gestation in the prediction of pre-eclampsia.
Gibbone E, Wright A, Vallenas Campos R, Sanchez Sierra A, Nicolaides KH, Charakida M.
Ultrasound Obstet Gynecol 2021;57:739-747 pdf -
Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia.
Garcia-Gonzalez C, Georgiopoulos G, Azim SA, Macaya F, Kametas N, Nihoyannopoulos P, Nicolaides KH, Charakida M.
Hypertension 2020;76:514-522. pdf -
Impact of gestational diabetes mellitus on fetal cardiac morphology and function: cohort comparison of second- and third-trimester fetuses.
Yovera L, Zaharia M, Jachymski T, Velicu-Scraba O, Coronel C, De Paco Matallana C, Georgiopoulos G, Nicolaides KH, Charakida M.
Ultrasound Obstet Gynecol 2021;57:607-613 pdf -
Fetal cardiac function at 35-37 weeks' gestation in pregnancies that subsequently develop pre-eclampsia.
Semmler J, Garcia-Gonzalez C, Sanchez Sierra A, Gallardo Arozena M, Nicolaides KH, Charakida M.
Ultrasound Obstet Gynecol 2021;57:417:422 pdf -
Cardiac function in gestational diabetes mellitus: A longitudinal study from fetal life to infancy.
Aguilera J, Semmler J, Anzoategui S, Zhang H, Nicolaides KH, Charakida M.
BJOG 2021;128:22-279 pdf -
Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin.
Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, Shehata H.
Obstet Med 2017;10:170-173. pdf -
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Effect of change in posture on maternal functional hemodynamics at 35-37 weeks' gestation.
Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;51:368-374. pdf -
Maternal cardiac function at 35-37 weeks' gestation: prediction of pre-eclampsia and gestational hypertension.
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:61-66. pdf -
Maternal cardiovascular function at 35-37 weeks' gestation: Relation to maternal characteristics.
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:39-45. pdf -
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H.
N Engl J Med 2016;374:434-43. pdf -
Inverted Pyramid of Care.
Sonek JD, Kagan KO, Nicolaides KH.
Clin Lab Med 2016;36:305-17. pdf -
Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis.
Galazis N, Docheva N, Simillis C, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2014;181:45-53. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Maternal serum retinol-binding protein-4 at 11-13weeks' gestation in normal and pathological pregnancies.
Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH.
Metabolism 2013;62:814-9. -
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012;61:699-705.